Amedeo Smart

Free Medical Literature Service

 

Amedeo

Vaccines
  Free Subscription

Articles published in
Virus Res
    April 2024
  1. AVIZINIENE A, Dalgediene I, Armalyte J, Petraityte-Burneikiene R, et al
    Immunogenicity of Novel vB_EcoS_NBD2 Bacteriophage-Originated Nanotubes as a Carrier for Peptide-Based Vaccines.
    Virus Res. 2024 Apr 11:199370. doi: 10.1016/j.virusres.2024.199370.
    >> Share

    March 2024
  2. CHOWDHURY IR, Viktorova E, Samal SK, Belov GA, et al
    The effect of 5' and 3' non-translated regions on the expression of a transgene from a Newcastle disease virus vector.
    Virus Res. 2024;341:199309.
    >> Share

    January 2024
  3. ZAHEDIPOUR F, Zahedipour F, Zamani P, Jaafari MR, et al
    Harnessing CRISPR Technology for Viral Therapeutics and Vaccines: From Preclinical Studies to Clinical Applications.
    Virus Res. 2024 Jan 9:199314. doi: 10.1016/j.virusres.2024.199314.
    >> Share

  4. DESMET C, Coelho-Cruz B, Mehn D, Colpo P, et al
    ASFV epitope mapping by high density peptides microarrays.
    Virus Res. 2024;339:199287.
    >> Share

    December 2023
  5. OTA K, Sakai H, Sasaki D, Mitsumoto-Kaseida F, et al
    Rapid increase in salivary IgA and broad recognition of spike protein following SARS-CoV-2 vaccination.
    Virus Res. 2023 Dec 4:199294. doi: 10.1016/j.virusres.2023.199294.
    >> Share

    November 2023
  6. HASSAN MSH, Ali A, Mahmoud ME, Altakrouni D, et al
    Protection of laying chickens against the Canadian DMV/1639 infectious bronchitis virus infection through priming with heterologous live vaccine and boosting with heterologous or homologous inactivated vaccine.
    Virus Res. 2023 Nov 21:199281. doi: 10.1016/j.virusres.2023.199281.
    >> Share

    August 2023
  7. KO MK, Kim HW, Park SH, Park JH, et al
    The role of zinc sulfate in enhancing cellular and humoral immune responses to foot-and-mouth disease vaccine.
    Virus Res. 2023 Aug 1:199189. doi: 10.1016/j.virusres.2023.199189.
    >> Share

    July 2023
  8. GUO Q, Zhu S, Wang D, Li X, et al
    Genetic characterization and molecular evolution of type 3 vaccine-derived polioviruses from an immunodeficient patient in China.
    Virus Res. 2023;334:199177.
    >> Share

  9. PRINS MLM, Prins C, de Vries JJC, Visser LG, et al
    Establishing immunogenicity and safety of needle-free intradermal delivery by nanoporous ceramic skin patch of mRNA SARS-CoV-2 vaccine as a revaccination strategy in healthy volunteers.
    Virus Res. 2023 Jul 18:199175. doi: 10.1016/j.virusres.2023.199175.
    >> Share

  10. GOLDEN JW, Fitzpatrick CJ, Suschak JJ, Clements TL, et al
    Induced protection from a CCHFV-M DNA vaccine requires CD8(+) T cells.
    Virus Res. 2023 Jul 15:199173. doi: 10.1016/j.virusres.2023.199173.
    >> Share

  11. SUN YY, Liu KS, Yun T, Ni Z, et al
    High expression of the classical swine fever virus (CSFV) envelope protein E2 by a single amino acid mutation and its embedded in the pseudorabies virus (PRV) vector for immunization.
    Virus Res. 2023;331:199111.
    >> Share

    June 2023
  12. TAI W, Zheng J, Zhang X, Shi J, et al
    MERS-CoV RBD-mRNA vaccine induces potent and broadly neutralizing antibodies with protection against MERS-CoV infection.
    Virus Res. 2023;334:199156.
    >> Share

  13. LIU R, Lv Y, Sun W, Li M, et al
    Investigation of a subunit protein vaccine for HFRS based on a consensus sequence between envelope glycoproteins of HTNV and SEOV.
    Virus Res. 2023;334:199149.
    >> Share

  14. SONG Y, Zhao Z, Liu L, Li Y, et al
    Knob domain of Fiber 2 protein provides full protection against fowl adenovirus serotype 4.
    Virus Res. 2023;330:199113.
    >> Share

    December 2022
  15. GALLI C, Pellegrinelli L, Giardina F, Ferrari G, et al
    On the lookout for influenza viruses in Italy during the 2021-2022 season: along came A(H3N2) viruses with a new phylogenetic makeup of their hemagglutinin.
    Virus Res. 2022 Dec 26:199033. doi: 10.1016/j.virusres.2022.199033.
    >> Share

  16. KOK BH, Lim HT, Lim CP, Lai NS, et al
    Dengue virus infection - a review of pathogenesis, vaccines, diagnosis and therapy.
    Virus Res. 2022;324:199018.
    >> Share

    October 2022
  17. YAN LN, Li D, Wang ZD, Jiang ZZ, et al
    Neutralizing antibodies and T-cell responses to inactivated SARS-Cov-2 vaccine in COVID-19 convalescents one and a half years after infection.
    Virus Res. 2022 Oct 22:198977. doi: 10.1016/j.virusres.2022.198977.
    >> Share

  18. HASSNINE AA, Saber MA, Fouad YM, Sarhan H, et al
    Clinical study on the efficacy of hepatitis B vaccination in hepatitis C virus related chronic liver diseases in Egypt.
    Virus Res. 2022 Oct 6:198953. doi: 10.1016/j.virusres.2022.198953.
    >> Share

  19. ZHENZHONG W, Chuanxiang Q, Shengqiang G, Jinming L, et al
    Genetic variation and evolution of attenuated African swine fever virus strain isolated in the field: A review.
    Virus Res. 2022;319:198874.
    >> Share

    September 2022
  20. LUO C, Wang Q, Guo R, Zhang J, et al
    A novel Pseudorabies virus vaccine developed using HDR-CRISPR/Cas9 induces strong humoral and cellular immune response in mice.
    Virus Res. 2022 Sep 26:198937. doi: 10.1016/j.virusres.2022.198937.
    >> Share

    August 2022
  21. HOU LN, Wang FX, Wang YX, Guo H, et al
    Subunit vaccine based on glycoprotein B protects pattern animal guinea pigs from tissue damage caused by infectious bovine rhinotracheitis virus.
    Virus Res. 2022;320:198899.
    >> Share

  22. ZHAO Z, Jiang FY, Zhou GQ, Duan HX, et al
    Protective immunity against spring viremia of carp virus by mannose modified chitosan loaded DNA vaccine.
    Virus Res. 2022 Aug 14:198896. doi: 10.1016/j.virusres.2022.198896.
    >> Share

    July 2022
  23. LEGNARDI M, Cecchinato M, Homonnay Z, Dauphin G, et al
    Viral subpopulation variability in different batches of Infectious bronchitis virus (IBV) vaccines based on GI-23 lineage: implications for the field.
    Virus Res. 2022 Jul 21:198877. doi: 10.1016/j.virusres.2022.198877.
    >> Share

  24. ABDOLI M, Shafaati M, Ghamsari LK, Abdoli A, et al
    Intranasal administration of cold-adapted live-attenuated SARS-CoV-2 candidate vaccine confers protection against SARS-CoV-2.
    Virus Res. 2022 Jul 9:198857. doi: 10.1016/j.virusres.2022.198857.
    >> Share

  25. LI J, Li S, Qiu M, Li X, et al
    Minor and major envelope proteins of PRRSV play synergistic roles in inducing heterologous neutralizing antibodies and conferring cross protection.
    Virus Res. 2022;315:198789.
    >> Share

    June 2022
  26. GONG Y, Sui L, Li Y
    Recombination in Papillomavirus: Controversy and Possibility.
    Virus Res. 2022;314:198756.
    >> Share

    May 2022
  27. JUNG MH, Nikapitiya C, Kim SJ, Han HJ, et al
    Protective immunity induced by ankyrin repeat-containing protein-based DNA vaccine against rock bream iridovirus (RBIV) in rock bream (Oplegnathus fasciatus).
    Virus Res. 2022 May 26:198827. doi: 10.1016/j.virusres.2022.198827.
    >> Share

  28. ROWLAND RRR, Doerksen T, Lu A, Sheahan M, et al
    Effect of the host genotype at a Porcine Reproductive and Respiratory Syndrome (PRRS) resistance marker on evolution of the modified-live PRRS vaccine virus in pigs.
    Virus Res. 2022;316:198809.
    >> Share

    April 2022
  29. ALMEIDA F, Santos LA, Trigueiro-Louro JM, RebelodeAndrade H, et al
    Optimization of A(H1N1)pdm09 vaccine seed viruses: the source of PB1 and HA vRNA as a major determinant for antigen yield.
    Virus Res. 2022 Apr 30:198795. doi: 10.1016/j.virusres.2022.198795.
    >> Share

  30. WEI N, Wang Q, Lin Z, Xu L, et al
    Systematic profiling of antigen bias in humoral response against SARS-CoV-2.
    Virus Res. 2022;312:198711.
    >> Share

    March 2022
  31. SILVA LMN, Santos MR, Carvalho JA, Carvalho OV, et al
    Molecular analysis of the full-length VP2 gene of Brazilian strains of canine parvovirus 2 shows genetic and structural variability between wild and vaccine strains.
    Virus Res. 2022 Mar 12:198746. doi: 10.1016/j.virusres.2022.198746.
    >> Share

  32. XU M, Zhang C, Liu Y, Chen S, et al
    A noval strategy of deletion in PK gene for construction of a vaccine candidate with exellent safety and complete protection efficiency against high virulent Chinese pseudorabies virus variant.
    Virus Res. 2022 Mar 7:198740. doi: 10.1016/j.virusres.2022.198740.
    >> Share

  33. AGBLA JM, Esona MD, Jaimes J, Gautam R, et al
    Whole genome analysis of rotavirus strains circulating in Benin before vaccine introduction, 2016-2018.
    Virus Res. 2022 Mar 2:198715. doi: 10.1016/j.virusres.2022.198715.
    >> Share

    January 2022
  34. PERBOLIANACHIS P, Ferla D, Arce R, Ferreiro I, et al
    Phylogenetic analysis of SARS-CoV-2 viruses circulating in the South American region: genetic relations and vaccine strain match.
    Virus Res. 2022 Jan 21:198688. doi: 10.1016/j.virusres.2022.198688.
    >> Share

    November 2021
  35. XIAO T, Leng H, Zhang Q, Chen Q, et al
    Isolation and characterization of a Sabin 3/Sabin 1 recombinant vaccine-derived poliovirus from a child with severe combined immunodeficiency.
    Virus Res. 2021 Nov 15:198633. doi: 10.1016/j.virusres.2021.198633.
    >> Share

  36. SUN Y, Li C, Li Z, Shangguan A, et al
    Quercetin as an antiviral agent inhibits the Pseudorabies virus in vitro and in vivo.
    Virus Res. 2021;305:198556.
    >> Share

  37. GUPTA D, Parthasarathy H, Sah V, Tandel D, et al
    Inactivation of SARS-CoV-2 by beta-propiolactone causes aggregation of viral particles and loss of antigenic potential.
    Virus Res. 2021;305:198555.
    >> Share

    September 2021
  38. LEI H, Li S, Lu X, Ren Y, et al
    Oral administration of Saccharomyces cerevisiae displaying VP28-VP24 confers protection against white spot syndrome virus in shrimp.
    Virus Res. 2021;302:198467.
    >> Share

    June 2021
  39. LEI L, Qin H, Luo J, Tan Y, et al
    Construction and immunological evaluation of hepatitis B virus core virus-like particles containing multiple antigenic peptides of respiratory syncytial virus.
    Virus Res. 2021;298:198410.
    >> Share

    May 2021
  40. BIDART J, Mignaqui A, Kornuta C, Lupi G, et al
    FMD empty capsids combined with the Immunostant Particle Adjuvant -ISPA or ISA206 induce protective immunity against foot and mouth disease virus.
    Virus Res. 2021;297:198339.
    >> Share

    April 2021
  41. YAN Z, Chen M, Tang D, Wu X, et al
    Better immune efficacy triggered by the inactivated gI/gE-deleted pseudorabies virus with the additional insertion of gC gene in mice and weaned pigs.
    Virus Res. 2021;296:198353.
    >> Share

  42. HU Z, Zhao J, Shi L, Hu J, et al
    Identification of the dominant non-neutralizing epitope in the haemagglutinin of H7N9 avian influenza virus.
    Virus Res. 2021;298:198409.
    >> Share

  43. KANAI Y, Kobayashi T
    Rotavirus reverse genetics systems: Development and application.
    Virus Res. 2021;295:198296.
    >> Share

    March 2021
  44. FEARON SH, Dennis SJ, Hitzeroth II, Rybicki EP, et al
    Humoral and cell-mediated immune responses to plant-produced African horse sickness virus VP7 quasi-crystals.
    Virus Res. 2021;294:198284.
    >> Share

  45. KOTAKI T, Yamanaka A, Konishi E, Kameoka M, et al
    A potent neutralizing mouse monoclonal antibody specific to dengue virus type 1 Mochizuki strain recognized a novel epitope around the N-67 glycan on the envelope protein: A possible explanation of dengue virus evolution regarding the acquisition of N
    Virus Res. 2021;294:198278.
    >> Share

    January 2021
  46. ANWAR MN, Guo S, Xin W, Hameed M, et al
    Adaptation of a live-attenuated genotype I Japanese encephalitis virus to vero cells is associated with mutations in structural protein genes.
    Virus Res. 2021;292:198256.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016